Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 85

1.

Estimated Annual Health and Cost Impact of PHiD-CV Immunization Program in Brazil.

Gomez JA, Lopes de Abreu AJ, Caceres DC, Nieto J, Ortega-Barria E.

Pediatr Infect Dis J. 2019 Oct;38(10):e260-e265. doi: 10.1097/INF.0000000000002436.

PMID:
31568144
2.

Vaccination herd effect experience in Latin America: a systematic literature review.

DeAntonio R, Amador S, Bunge EM, Eeuwijk J, Prado-Cohrs D, Nieto Guevara J, Rubio MDP, Ortega-Barria E.

Hum Vaccin Immunother. 2019;15(1):49-71. doi: 10.1080/21645515.2018.1514225. Epub 2018 Sep 19.

3.

Pneumococcal meningitis trends after pneumococcal conjugate vaccine introduction in Colombia: An interrupted time-series analysis.

Caceres DC, Ortega-Barria E, Nieto J, DeAntonio R.

Hum Vaccin Immunother. 2018 May 4;14(5):1230-1233. doi: 10.1080/21645515.2018.1425115. Epub 2018 Feb 12.

4.

A cross-sectional study assessing the pharyngeal carriage of Neisseria meningitidis in subjects aged 1-24 years in the city of Embu das Artes, São Paulo, Brazil.

Weckx LY, Puccini RF, Machado A, Gonçalves MG, Tuboi S, de Barros E, Devadiga R, Ortega-Barria E, Colindres R.

Braz J Infect Dis. 2017 Nov - Dec;21(6):587-595. doi: 10.1016/j.bjid.2017.06.005. Epub 2017 Jul 14.

5.

Efficacy of 10-valent pneumococcal non-typeable Haemophilus influenzae protein D conjugate vaccine against acute otitis media and nasopharyngeal carriage in Panamanian children - A randomized controlled trial.

Sáez-Llorens X, Rowley S, Wong D, Rodríguez M, Calvo A, Troitiño M, Salas A, Vega V, Castrejón MM, Lommel P, Pascal TG, Hausdorff WP, Borys D, Ruiz-Guiñazú J, Ortega-Barría E, Yarzabal JP, Schuerman L.

Hum Vaccin Immunother. 2017 Jun 3;13(6):1-16. doi: 10.1080/21645515.2017.1287640. Epub 2017 Feb 25.

6.

Etiology of acute otitis media and serotype distribution of Streptococcus pneumoniae and Haemophilus influenzae in Chilean children <5 years of age.

Rosenblut A, Napolitano C, Pereira A, Moreno C, Kolhe D, Lepetic A, Ortega-Barria E.

Medicine (Baltimore). 2017 Feb;96(6):e5974. doi: 10.1097/MD.0000000000005974.

7.

Efficacy, safety and effectiveness of licensed rotavirus vaccines: a systematic review and meta-analysis for Latin America and the Caribbean.

Velázquez RF, Linhares AC, Muñoz S, Seron P, Lorca P, DeAntonio R, Ortega-Barria E.

BMC Pediatr. 2017 Jan 13;17(1):14. doi: 10.1186/s12887-016-0771-y. Review.

8.

Sustained Decrease in Gastroenteritis-related Deaths and Hospitalizations in Children Less Than 5 Years of Age After the Introduction of Rotavirus Vaccination: A Time-Trend Analysis in Brazil (2001-2010).

Costa I, Linhares AC, Cunha MH, Tuboi S, Argüello DF, Justino MC, Gopala K, Ortega-Barria E, Colindres R.

Pediatr Infect Dis J. 2016 Jun;35(6):e180-90. doi: 10.1097/INF.0000000000001143.

PMID:
26991061
9.

Correction: Efficacy of Pneumococcal Nontypable Haemophilus influenzae Protein D Conjugate Vaccine (PHiD-CV) in Young Latin American Children: A Double-Blind Randomized Controlled Trial.

Tregnaghi MW, Sáez-Llorens X, López P, Abate H, Smith E, Pósleman A, Calvo A, Wong D, Cortes-Barbosa C, Ceballos A, Tregnaghi M, Sierra A, Rodriguez M, Troitiño M, Carabajal C, Falaschi A, Leandro A, Castrejón MM, Lepetic A, Lommel P, Hausdorff WP, Borys D, Ruiz Guiñazú J, Ortega-Barría E, Yarzábal JP, Schuerman L; COMPAS Group.

PLoS Med. 2015 Jun 26;12(6):e1001850. doi: 10.1371/journal.pmed.1001850. eCollection 2015 Jun. No abstract available.

10.

Impact of Hepatitis A vaccination with a two-dose schedule in Panama: Results of epidemiological surveillance and time trend analysis.

Estripeaut D, Contreras R, Tinajeros O, Castrejón MM, Shafi F, Ortega-Barria E, DeAntonio R.

Vaccine. 2015 Jun 22;33(28):3200-7. doi: 10.1016/j.vaccine.2015.04.100. Epub 2015 May 14.

11.

Rotavirus strain surveillance for three years following the introduction of rotavirus vaccine into Belém, Brazil.

Guerra SF, Linhares AC, Mascarenhas JD, Oliveira A, Justino MC, Soares LS, Müller EC, Brasil P, Tuboi S, Ortega-Barria E, Colindres R.

J Med Virol. 2015 Aug;87(8):1303-10. doi: 10.1002/jmv.24183. Epub 2015 Apr 16.

PMID:
25879653
12.

Etiology and antimicrobial susceptibility of middle ear fluid pathogens in Costa Rican children with otitis media before and after the introduction of the 7-valent pneumococcal conjugate vaccine in the National Immunization Program: acute otitis media microbiology in Costa Rican children.

Abdelnour A, Arguedas A, Dagan R, Soley C, Porat N, Castrejon MM, Ortega-Barria E, Colindres R, Pirçon JY, DeAntonio R, Van Dyke MK.

Medicine (Baltimore). 2015 Jan;94(2):e320. doi: 10.1097/MD.0000000000000320.

13.

Efficacy of pneumococcal nontypable Haemophilus influenzae protein D conjugate vaccine (PHiD-CV) in young Latin American children: A double-blind randomized controlled trial.

Tregnaghi MW, Sáez-Llorens X, López P, Abate H, Smith E, Pósleman A, Calvo A, Wong D, Cortes-Barbosa C, Ceballos A, Tregnaghi M, Sierra A, Rodriguez M, Troitiño M, Carabajal C, Falaschi A, Leandro A, Castrejón MM, Lepetic A, Lommel P, Hausdorff WP, Borys D, Ruiz Guiñazú J, Ortega-Barría E, Yarzábal JP, Schuerman L; COMPAS Group.

PLoS Med. 2014 Jun 3;11(6):e1001657. doi: 10.1371/journal.pmed.1001657. eCollection 2014 Jun. Erratum in: PLoS Med. 2015 Jun;12(6):e1001850.

14.

Seroprevalences of varicella-zoster virus, herpes simplex virus and cytomegalovirus in a cross-sectional study in Mexico.

Conde-Glez C, Lazcano-Ponce E, Rojas R, DeAntonio R, Romano-Mazzotti L, Cervantes Y, Ortega-Barria E.

Vaccine. 2013 Oct 17;31(44):5067-74. doi: 10.1016/j.vaccine.2013.08.077. Epub 2013 Sep 7.

PMID:
24021305
15.

Seroprevalence of Bordetella pertussis in the Mexican population: a cross-sectional study.

Conde-Glez C, Lazcano-Ponce E, Rojas R, DeAntonio R, Romano-Mazzotti L, Cervantes Y, Ortega-Barría E.

Epidemiol Infect. 2014 Apr;142(4):706-13. doi: 10.1017/S0950268813001313. Epub 2013 Jun 5.

PMID:
23734968
16.

A multi-country study of intussusception in children under 2 years of age in Latin America: analysis of prospective surveillance data.

Sáez-Llorens X, Velázquez FR, Lopez P, Espinoza F, Linhares AC, Abate H, Nuñez E, Venegas G, Vergara R, Jimenez AL, Rivera M, Aranza C, Richardson V, Macias-Parra M, Palacios GR, Rivera L, Ortega-Barria E, Cervantes Y, Rüttimann R, Rubio P, Acosta CJ, Newbern C, Verstraeten T, Breuer T.

BMC Gastroenterol. 2013 May 27;13:95. doi: 10.1186/1471-230X-13-95.

17.

Seroprevalence of hepatitis A virus in a cross-sectional study in Mexico: Implications for hepatitis A vaccination.

Lazcano-Ponce E, Conde-Gonzalez C, Rojas R, DeAntonio R, Romano-Mazzotti L, Cervantes Y, Ortega-Barria E.

Hum Vaccin Immunother. 2013 Feb;9(2):375-81. Epub 2013 Jan 4.

18.

Burden of influenza in Latin America and the Caribbean: a systematic review and meta-analysis.

Savy V, Ciapponi A, Bardach A, Glujovsky D, Aruj P, Mazzoni A, Gibbons L, Ortega-Barría E, Colindres RE.

Influenza Other Respir Viruses. 2013 Nov;7(6):1017-32. doi: 10.1111/irv.12036. Epub 2012 Dec 5. Review.

19.

The use of an adequate mathematical model is crucial to evaluate vaccine effectiveness.

Gomez JA, Nieto J, Range M, Ortega-Barria E.

Mem Inst Oswaldo Cruz. 2012 Aug;107(5):702-4. No abstract available.

20.

Postmarketing surveillance of intussusception following mass introduction of the attenuated human rotavirus vaccine in Mexico.

Velázquez FR, Colindres RE, Grajales C, Hernández MT, Mercadillo MG, Torres FJ, Cervantes-Apolinar M, DeAntonio-Suarez R, Ortega-Barria E, Blum M, Breuer T, Verstraeten T.

Pediatr Infect Dis J. 2012 Jul;31(7):736-44. doi: 10.1097/INF.0b013e318253add3.

PMID:
22695189
21.

Streptococcus pneumoniae serotype 19A in Latin America and the Caribbean: a systematic review and meta-analysis, 1990-2010.

Castañeda E, Agudelo CI, De Antonio R, Rosselli D, Calderón C, Ortega-Barria E, Colindres RE.

BMC Infect Dis. 2012 May 28;12:124. doi: 10.1186/1471-2334-12-124. Review.

22.

Non-capsulated and capsulated Haemophilus influenzae in children with acute otitis media in Venezuela: a prospective epidemiological study.

Naranjo L, Suarez JA, DeAntonio R, Sanchez F, Calvo A, Spadola E, Rodríguez N, Andrade O, Bertuglia F, Márquez N, Castrejon MM, Ortega-Barria E, Colindres RE.

BMC Infect Dis. 2012 Feb 15;12:40. doi: 10.1186/1471-2334-12-40.

23.

Impact of rotavirus vaccination on childhood gastroenteritis-related mortality and hospital discharges in Panama.

Bayard V, DeAntonio R, Contreras R, Tinajero O, Castrejon MM, Ortega-Barría E, Colindres RE.

Int J Infect Dis. 2012 Feb;16(2):e94-8. doi: 10.1016/j.ijid.2011.09.003. Epub 2011 Dec 7.

24.

Horizontal transmission of a human rotavirus vaccine strain--a randomized, placebo-controlled study in twins.

Rivera L, Peña LM, Stainier I, Gillard P, Cheuvart B, Smolenov I, Ortega-Barria E, Han HH.

Vaccine. 2011 Nov 28;29(51):9508-13. doi: 10.1016/j.vaccine.2011.10.015. Epub 2011 Oct 18.

25.

Burden and typing of rotavirus group A in Latin America and the Caribbean: systematic review and meta-analysis.

Linhares AC, Stupka JA, Ciapponi A, Bardach AE, Glujovsky D, Aruj PK, Mazzoni A, Rodriguez JA, Rearte A, Lanzieri TM, Ortega-Barria E, Colindres R.

Rev Med Virol. 2011 Mar;21(2):89-109. doi: 10.1002/rmv.682. Epub 2011 Mar 7. Review.

PMID:
21384462
26.

Human rotavirus vaccine is highly efficacious when coadministered with routine expanded program of immunization vaccines including oral poliovirus vaccine in Latin America.

Tregnaghi MW, Abate HJ, Valencia A, Lopez P, Da Silveira TR, Rivera L, Rivera Medina DM, Saez-Llorens X, Gonzalez Ayala SE, De León T, Van Doorn LJ, Pilar Rubio MD, Suryakiran PV, Casellas JM, Ortega-Barria E, Smolenov IV, Han HH; Rota-024 Study Group.

Pediatr Infect Dis J. 2011 Jun;30(6):e103-8. doi: 10.1097/INF.0b013e3182138278.

PMID:
21378594
27.

Impact of rotavirus vaccination on childhood deaths from diarrhea in Brazil.

Lanzieri TM, Linhares AC, Costa I, Kolhe DA, Cunha MH, Ortega-Barria E, Colindres RE.

Int J Infect Dis. 2011 Mar;15(3):e206-10. doi: 10.1016/j.ijid.2010.11.007. Epub 2010 Dec 28.

28.

Effectiveness of the monovalent G1P[8] human rotavirus vaccine against hospitalization for severe G2P[4] rotavirus gastroenteritis in Belém, Brazil.

Justino MC, Linhares AC, Lanzieri TM, Miranda Y, Mascarenhas JD, Abreu E, Guerra SF, Oliveira AS, da Silva VB, Sanchez N, Meyer N, Shafi F, Ortega-Barria E, Soriano-Gabarró M, Colindres RE.

Pediatr Infect Dis J. 2011 May;30(5):396-401. doi: 10.1097/INF.0b013e3182055cc2.

PMID:
21150692
29.

Rotavirus genotypes in Costa Rica, Nicaragua, Honduras and the Dominican Republic.

Bourdett-Stanziola L, Ortega-Barria E, Espinoza F, Bucardo F, Jimenez C, Ferrera A.

Intervirology. 2011;54(1):49-52. doi: 10.1159/000318863. Epub 2010 Aug 6.

30.

Screening of Latin American plants for antiparasitic activities against malaria, Chagas disease, and leishmaniasis.

Calderón AI, Romero LI, Ortega-Barría E, Solís PN, Zacchino S, Gimenez A, Pinzón R, Cáceres A, Tamayo G, Guerra C, Espinosa A, Correa M, Gupta MP.

Pharm Biol. 2010 May;48(5):545-53. doi: 10.3109/13880200903193344.

PMID:
20645798
31.

Rotavirus genotypes in Costa Rica, Nicaragua, Honduras and the Dominican Republic.

Bourdett-Stanziola L, Ortega-Barria E, Espinoza F, Bucardo F, Jimenez C, Ferrera A.

Intervirology. 2010;53(6):390-3. doi: 10.1159/000317288. Epub 2010 Jul 2.

32.

Trends in hospitalizations from all-cause gastroenteritis in children younger than 5 years of age in Brazil before and after human rotavirus vaccine introduction, 1998-2007.

Lanzieri TM, Costa I, Shafi FA, Cunha MH, Ortega-Barria E, Linhares AC, Colindres RE.

Pediatr Infect Dis J. 2010 Jul;29(7):673-5. doi: 10.1097/INF.0b013e3181da8f23.

PMID:
20300045
33.

Diversity of human rotavirus G and P genotypes in Panama, Costa Rica, and the Dominican Republic.

Bourdett-Stanziola L, Jiménez C, Ortega-Barria E.

Am J Trop Med Hyg. 2008 Dec;79(6):921-4.

PMID:
19052306
34.

Viridamides A and B, lipodepsipeptides with antiprotozoal activity from the marine cyanobacterium Oscillatoria nigro-viridis.

Simmons TL, Engene N, Ureña LD, Romero LI, Ortega-Barría E, Gerwick L, Gerwick WH.

J Nat Prod. 2008 Sep;71(9):1544-50. doi: 10.1021/np800110e. Epub 2008 Aug 21.

35.

Coibamide A, a potent antiproliferative cyclic depsipeptide from the Panamanian marine cyanobacterium Leptolyngbya sp.

Medina RA, Goeger DE, Hills P, Mooberry SL, Huang N, Romero LI, Ortega-Barría E, Gerwick WH, McPhail KL.

J Am Chem Soc. 2008 May 21;130(20):6324-5. doi: 10.1021/ja801383f. Epub 2008 Apr 29.

36.

Efficacy and safety of an oral live attenuated human rotavirus vaccine against rotavirus gastroenteritis during the first 2 years of life in Latin American infants: a randomised, double-blind, placebo-controlled phase III study.

Linhares AC, Velázquez FR, Pérez-Schael I, Sáez-Llorens X, Abate H, Espinoza F, López P, Macías-Parra M, Ortega-Barría E, Rivera-Medina DM, Rivera L, Pavía-Ruz N, Nuñez E, Damaso S, Ruiz-Palacios GM, De Vos B, O'Ryan M, Gillard P, Bouckenooghe A; Human Rotavirus Vaccine Study Group.

Lancet. 2008 Apr 5;371(9619):1181-9. doi: 10.1016/S0140-6736(08)60524-3.

PMID:
18395579
37.

[Economic impact of rotavirus vaccination in Panama].

Constenla D, Ortega-Barría E, Rheingans RD, Antil L, Sáez-Llorens X.

An Pediatr (Barc). 2008 Feb;68(2):128-35. Spanish.

38.

The immunogenicity and reactogenicity of DTPw-HBV/Hib 2.5 combination vaccine: results from four phase III multicenter trials across three continents.

Ortega-Barrìa E, Kanra G, Leroux G, Bravo L, Safary A, Lefevre I; DTPw-HBV/Hib 2.5 study group.

Vaccine. 2007 Dec 5;25(50):8432-40. Epub 2007 Oct 9.

PMID:
17961876
39.

Hydroxyalkenylresorcinols from Stylogyne turbacensis.

Jiménez-Romero C, Torres-Mendoza D, Ureña González LD, Ortega-Barría E, McPhail KL, Gerwick WH, Cubilla-Rios L.

J Nat Prod. 2007 Aug;70(8):1249-52. Epub 2007 Jul 13.

PMID:
17629327
40.

Benefit of vitamin A supplementation on ascaris reinfection is less evident in stunted children.

Payne LG, Koski KG, Ortega-Barria E, Scott ME.

J Nutr. 2007 Jun;137(6):1455-9.

PMID:
17513406
41.

Antimalarial linear lipopeptides from a Panamanian strain of the marine cyanobacterium Lyngbya majuscula.

McPhail KL, Correa J, Linington RG, Gonzalez J, Ortega-Barría E, Capson TL, Gerwick WH.

J Nat Prod. 2007 Jun;70(6):984-8. Epub 2007 Apr 19.

42.

Venturamides A and B: antimalarial constituents of the panamanian marine Cyanobacterium Oscillatoria sp.

Linington RG, Gonzalez J, Ureña LD, Romero LI, Ortega-Barría E, Gerwick WH.

J Nat Prod. 2007 Mar;70(3):397-401. Epub 2007 Mar 1.

PMID:
17328572
43.

Predominance of Trypanosoma cruzi I among Panamanian sylvatic isolates.

Samudio F, Ortega-Barría E, Saldaña A, Calzada J.

Acta Trop. 2007 Feb;101(2):178-81. Epub 2007 Jan 10.

PMID:
17288977
44.

Antiplasmodial metabolites isolated from the marine octocoral Muricea austera.

Gutiérrez M, Capson TL, Guzman HM, Gonzalez J, Ortega-Barría E, Quiñoa E, Riguera R.

J Nat Prod. 2006 Oct;69(10):1379-83.

PMID:
17067146
45.

Weakly antimalarial flavonol arabinofuranosides from Calycolpus warszewiczianus.

Torres-Mendoza D, González J, Ortega-Barría E, Heller MV, Capson TL, McPhail K, Gerwick WH, Cubilla-Rios L.

J Nat Prod. 2006 May;69(5):826-8.

PMID:
16724851
46.

Use of the polymerase chain reaction for diagnosing bovine tuberculosis in Panama.

Cedeño I, de Obaldía R, Sanjur O, Bayard V, Ortega-Barría E, Escobar C.

Rev Sci Tech. 2005 Dec;24(3):1067-75.

47.

Minor alkaloids from Guatteria dumetorum with antileishmanial activity.

Correa JE, Ríos CH, del Rosario Castillo A, Romero LI, Ortega-Barría E, Coley PD, Kursar TA, Heller MV, Gerwick WH, Rios LC.

Planta Med. 2006 Feb;72(3):270-2.

PMID:
16534735
48.

Safety and efficacy of an attenuated vaccine against severe rotavirus gastroenteritis.

Ruiz-Palacios GM, Pérez-Schael I, Velázquez FR, Abate H, Breuer T, Clemens SC, Cheuvart B, Espinoza F, Gillard P, Innis BL, Cervantes Y, Linhares AC, López P, Macías-Parra M, Ortega-Barría E, Richardson V, Rivera-Medina DM, Rivera L, Salinas B, Pavía-Ruz N, Salmerón J, Rüttimann R, Tinoco JC, Rubio P, Nuñez E, Guerrero ML, Yarzábal JP, Damaso S, Tornieporth N, Sáez-Llorens X, Vergara RF, Vesikari T, Bouckenooghe A, Clemens R, De Vos B, O'Ryan M; Human Rotavirus Vaccine Study Group.

N Engl J Med. 2006 Jan 5;354(1):11-22.

49.

3-Farnesyl-2-hydroxybenzoic acid is a new anti-Helicobacter pylori compound from Piper multiplinervium.

Rüegg T, Calderón AI, Queiroz EF, Solís PN, Marston A, Rivas F, Ortega-Barría E, Hostettmann K, Gupta MP.

J Ethnopharmacol. 2006 Feb 20;103(3):461-7. Epub 2005 Nov 2.

PMID:
16266794
50.

Caucanolides A-F, unusual antiplasmodial constituents from a colombian collection of the gorgonian coral Pseudopterogorgia bipinnata.

Ospina CA, Rodríguez AD, Sánchez JA, Ortega-Barria E, Capson TL, Mayer AM.

J Nat Prod. 2005 Oct;68(10):1519-26.

PMID:
16252918

Supplemental Content

Loading ...
Support Center